The effects of histamine and some histamine-like agonists on blood pressure in the cat

Insights

Histamine affects blood pressure via H1 and H2 receptors. Selective agonists confirm these roles, with 2-methylhistamine and 4-methylhistamine showing dose-dependent interactions with both receptor types.

Area of Science:

  • Pharmacology
  • Cardiovascular Physiology

Background:

  • Histamine is a key mediator in physiological processes, including cardiovascular regulation.
  • Understanding histamine's cardiovascular effects is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the specific roles of histamine H1 and H2 receptors in mediating histamine's effects on blood pressure.
  • To evaluate the utility of histamine-like agonists as pharmacological tools.

Main Methods:

  • Experiments were conducted on anesthetized cats.
  • The effects of histamine and four selective histamine-like agonists on blood pressure were recorded.
  • Dose-response relationships were analyzed to determine receptor interactions.

Main Results:

  • Histamine-induced depressor responses involve both H1 and H2 receptors.
  • Selective H1 agonists (2-(2-aminoethyl)pyridine, 2-(2-aminoethyl)thiazole) consistently lowered blood pressure.
  • 2-Methylhistamine and 4-methylhistamine exhibited dose-dependent interactions with both H1 and H2 receptors, influencing blood pressure.
  • Lower doses of 2-methylhistamine acted on H1 receptors, while higher doses may involve H2 receptors.
  • Lower doses of 4-methylhistamine acted on H2 receptors, while higher doses may involve H1 receptors.

Conclusions:

  • The study confirms the involvement of both H1 and H2 receptors in histamine's hypotensive effects.
  • Specific histamine-like agonists demonstrate differential receptor interactions, offering valuable tools for cardiovascular research.
  • The dose-dependent nature of agonist activity highlights the complexity of histamine receptor pharmacology in vivo.

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...